APA

Swardfager W., Hennebelle M., Yu D., Hammock B. D., Levitt A. J., Hashimoto K. & Taha A. Y. (20190218). Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. : Neuroscience and biobehavioral reviews.

Chicago

Swardfager W, Hennebelle M, Yu D, Hammock B D, Levitt A J, Hashimoto K and Taha A Y. 20190218. Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. : Neuroscience and biobehavioral reviews.

Harvard

Swardfager W., Hennebelle M., Yu D., Hammock B. D., Levitt A. J., Hashimoto K. and Taha A. Y. (20190218). Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. : Neuroscience and biobehavioral reviews.

MLA

Swardfager W, Hennebelle M, Yu D, Hammock B D, Levitt A J, Hashimoto K and Taha A Y. Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. : Neuroscience and biobehavioral reviews. 20190218.